0001104659-16-107576.txt : 20160325 0001104659-16-107576.hdr.sgml : 20160325 20160325112153 ACCESSION NUMBER: 0001104659-16-107576 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160324 FILED AS OF DATE: 20160325 DATE AS OF CHANGE: 20160325 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nivalis Therapeutics, Inc. CENTRAL INDEX KEY: 0001626199 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208969493 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3122 STERLING CIRCLE, SUITE 200 CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 720-945-7700 MAIL ADDRESS: STREET 1: 3122 STERLING CIRCLE, SUITE 200 CITY: BOULDER STATE: CO ZIP: 80301 FORMER COMPANY: FORMER CONFORMED NAME: N30 Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20141121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Congleton Jon CENTRAL INDEX KEY: 0001644975 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37449 FILM NUMBER: 161529033 MAIL ADDRESS: STREET 1: 3122 STERLING CIRCLE, SUITE 200 CITY: BOULDER STATE: CO ZIP: 80301 4 1 a4.xml 4 X0306 4 2016-03-24 0 0001626199 Nivalis Therapeutics, Inc. NVLS 0001644975 Congleton Jon C/O NIVALIS THERAPEUTICS, INC. 3122 STERLING CIRCLE, SUITE 200 BOULDER CO 80301 1 1 0 0 President and CEO Common Stock 2016-03-24 4 P 0 5000 4.2169 A 15000 D The price recorded in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.20 to $4.25, inclusive. The reporting person undertakes to provide Nivalis Therapeutics, Inc., any security holder of Nivalis Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. /s/ R. Michael Carruthers, Attorney-in-Fact 2016-03-25